#aaeth ,,congress #b;d ,session ,h4 ,r4 #egbc ,,an ,,act ,to require the ,medicare ,payment ,advisory ,commission to report on opioid payment1 adverse incentives1 and data under the ,medicare program4 #a4 ,short title ,this ,act may be cited as the ,expanding ,oversight of ,opioid ,prescribing and ,payment ,act of #bjah4 #b4 ,medicare ,payment ,advisory ,commission report on opioid payment1 adverse incentives1 and data under the ,medicare program ,not later than ,march #ae1 #bjai1 the ,medicare ,payment ,advisory ,commission shall submit to ,congress a report on1 with respect to the ,medicare program under title ,,xviii of the ,social ,security ,act1 the following3 7#a7 ,a description of how the ,medicare program pays for pain management treatments 7both opioid and non-opioid pain management alternatives7 in both inpatient and outpatient hospital settings4 7#b7 ,the identification of incentives under the hospital inpatient prospective payment system under section #ahhf of the ,social ,security ,act 7#db ,u4,s4,c4 #acieww7 and incentives under the hospital outpatient prospective payment system under section #ahcc7t7 of such ,act 7#db ,u4,s4,c4 #aciel7t77 for prescribing opioids and incentives under each such system for prescribing non-opioid treatments1 and recommendations as the ,commission deems appropriate for addressing any of such incentives that are adverse incentives4 7#c7 ,a description of how opioid use is tracked and monitored through ,medicare claims data and other mechanisms and the identification of any areas in which further data and methods are needed for improving data and understanding of opioid use4 #c4 ,no additional funds authorized ,no additional funds are authorized to be appropriated to carry out the requirements of this ,act4 ,such requirements shall be carried out using amounts otherwise authorized to be appropriated4 ,passed the ,house of ,representatives ,june #ai1 #bjah4;,clerk4